Print Page  |  Close Window

Investor Overview

NASDAQ: XBIT0.074.13Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
10/31/18XBiotech Highlights Third Quarter Developments for 2018Printer Friendly Version
10/26/18XBiotech Announces New Patents for Third Quarter 2018Printer Friendly Version
10/24/18XBiotech Announces Dismissal of Securities Class Action SuitPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »